BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 233 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,328,570 | -59.1% | 470,137 | -59.3% | 0.02% | -57.4% |
| Q2 2023 | $8,136,290 | -52.0% | 1,155,723 | -43.2% | 0.05% | -54.8% |
| Q1 2023 | $16,966,421 | +0.7% | 2,034,343 | +38.6% | 0.10% | -8.8% |
| Q4 2022 | $16,853,857 | +221.1% | 1,468,106 | +252.5% | 0.11% | +178.0% |
| Q3 2022 | $5,248,000 | +1361.8% | 416,526 | +452.7% | 0.04% | +925.0% |
| Q2 2020 | $359,000 | +897.2% | 75,363 | +316.4% | 0.00% | – |
| Q1 2020 | $36,000 | -99.5% | 18,100 | -99.1% | 0.00% | -100.0% |
| Q4 2019 | $7,302,000 | +56.6% | 2,116,417 | +30.0% | 0.07% | +26.3% |
| Q3 2019 | $4,664,000 | +4178.9% | 1,627,785 | +2212.2% | 0.06% | +2750.0% |
| Q2 2013 | $109,000 | – | 70,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |